Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Global Pseudomonas Aeruginosa Infection Treatment Market" report has been added to ResearchAndMarkets.com's offering. The global pseudomonas aeruginosa ...
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Infection Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. As the healthcare ...
Pseudomonas aeruginosa is an opportunistic pathogen that can cause acute and chronic infections. Responsible for many hospital-acquired infections, it is also a major concern for people with cystic ...
The Pseudomonas Aeruginosa Infection Treatment Market addresses the management of infections caused by the opportunistic pathogen Pseudomonas aeruginosa. This bacterium poses a significant threat, ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Pseudomonas Aeruginosa Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been ...
Wilmington, Delaware, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - TMR study for pseudomonas aeruginosa infection treatment market statistics, estimates a CAGR ...
The hospital pathogen Pseudomonas aeruginosa requires the sugar-binding proteins LecA and LecB to form biofilms as well as to attach to and penetrate host cells. These so-called lectins are therefore ...
Researchers at Ruhr-Universität Bochum (RUB) have studied how different drugs affect the difficult-to-treat bacterium Pseudomonas aeruginosa. According to the World Health Organisation, new treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results